Fat hypertrophy (Q44198): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
Hipertrofia focal do tecido adiposo subcutâneo. É uma sequela comum da injeção de insulina na pele por longo prazo.
description / endescription / en
 
Focal hypertrophy of subcutaneous adipose tissue. It is a common sequela of long-term insulin injection into the skin.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/302826287 / rank
 
Normal rank
Property / CURIE
 
CID11:EF02.0
Property / CURIE: CID11:EF02.0 / rank
 
Normal rank
Property / Canary Token
 
dki-india-EF02.0
Property / Canary Token: dki-india-EF02.0 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: L98.8 / rank
 
Normal rank

Latest revision as of 11:34, 13 August 2026

Focal hypertrophy of subcutaneous adipose tissue. It is a common sequela of long-term insulin injection into the skin.
Language Label Description Also known as
default for all languages
EF02.0
    English
    Fat hypertrophy
    Focal hypertrophy of subcutaneous adipose tissue. It is a common sequela of long-term insulin injection into the skin.

      Statements

      CID11:EF02.0
      0 references
      dki-india-EF02.0
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references